Keeping up with health and wellness news from Pennsylvania
Provided by AGP
AGP Picks
View all
Perspectify News
Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Filter
12 minutes ago
KFF Health Tracking Poll: MAHA and the Midterms
3 hours ago
AI firm sued over chatbots’ medical advice
![Should terminally ill patients in Pennsylvania be allowed to die with the help of a doctor? [poll]](https://bloximages.newyork1.vip.townnews.com/lancasteronline.com/content/tncms/assets/v3/editorial/6/a6/6a6b7693-c839-46df-9280-b9be32471aee/69fa4fcd6a468.image.jpg?crop=1763%2C926%2C0%2C124&resize=1200%2C630&order=crop%2Cresize)
Press releases
Publish your press release
17 hours ago
Governor Shapiro Makes $10 Million Investment to Build More Affordable Housing Across Pennsylvania Through New Mixed-Use Pilot Program
Pennsylvania Department of Community & Economic Development
This funding, through the Pennsylvania Mixed-Use Housing Development Pilot Program, will invest in seven projects that will create more than 1,400 new homes and apartments.
17 hours ago
Governor Shapiro Makes $10 Million Investment to Build More Affordable Housing Across Pennsylvania Through New Mixed-Use Pilot Program
Pennsylvania Department of Community & Economic Development
This funding, through the Pennsylvania Mixed-Use Housing Development Pilot Program, will invest in seven projects that will create more than 1,400 new homes and apartments.
May. 5, 2026
WellSpan Health opens Carlisle hospital, expanding emergency care in a growing Cumberland County corridor
GlobeNewswire, Inc.
York, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- WellSpan Health has officially opened WellSpan Carlisle Hospital, strengthening access to emergency and inpatient care for residents of Cumberland County as population growth continues to reshape the...
May. 5, 2026
Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer
GlobeNewswire, Inc.
Global Phase 3, randomized, controlled trial comparing azenosertib to standard-of-care chemotherapy now enrolling ASPENOVA designed as confirmatory study to support DENALI Phase 2 accelerated approval pathway, pending FDA feedback SAN DIEGO, May...
May. 5, 2026
Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference
GlobeNewswire, Inc.
RADNOR, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD),...
May. 4, 2026
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program
GlobeNewswire, Inc.
RESEARCH TRIANGLE PARK, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in...
Video Stories
Discover Affinity Group Publishing
Sign up for:
Harrisburg Wellness Reporter
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.
Explore More
